“Rationale and Design of a Study on D-Dimer Use to Stratify Patients After a First Unprovoked Venous Thromboembolism for Their Risk of Recurrence: Extended Low-Dose Apixaban Given Only to Patients With Positive D-Dimer Results: The Apidulcis Study”. 2022. Bleeding, Thrombosis and Vascular Biology 1 (1). https://doi.org/10.4081/btvb.2022.10.